Skip to main content
Clinical Trials/CTRI/2023/11/059644
CTRI/2023/11/059644
Recruiting
Phase 2

Comparative Clinical & Radiographic Evaluation of Autologous Advanced Platelet Rich Fibrin (A-PRF+) with Bioactive Glass (PerioGlas®) & Autologous Advanced Platelet Rich Fibrin (A-PRF+) with Demineralized Freeze Dried Bone Allograft (DFDBA) in the Treatment of Intrabony Defects in Chronic Periodontitis Patients- A Randomized Clinical Trial

Dr Monika Patil0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: M278- Other specified diseases of jawsHealth Condition 3: M858- Other specified disorders of bonedensity and structure
Sponsor
Dr Monika Patil
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Monika Patil

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients in the age group between 30\-60 yrs.
  • 2\)Patients diagnosed with Chronic Periodontitis.
  • 3\)Patients who are non\-smokers or do not consume tobacco in any other form.
  • 4\)Patients are in good systemic health with no contraindication to periodontal surgery.
  • 5\) Patients having pocket depths \>5mm, intraosseous defects \> 3mm and with radiographic evidence of vertical / angular bone loss in the affected sites.

Exclusion Criteria

  • 1\) One\-walled osseous defects.
  • 2\) Patients suffering from any systemic diseases or with a compromised immune system.
  • 3\) Patients who had received any type of periodontal therapy for the past 6 months.
  • 4\) Patients taking immunosuppressant drugs like corticosteroids.
  • 5\) Patients with a known history of allergy to Doxycycline or Chlorhexidine or any other medicine used in the study.
  • 6\) Patients showing unacceptable oral hygiene compliance during / after Phase I periodontal therapy.
  • 7\) Patients taking any drug known to cause gingival enlargement.
  • 8\) Pregnant and/or lactating mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Evaluation of success & failure of Mineral Trioxide Aggregate (MTA) & Biodentine in pulp therapy of second mandibular primary molar with irreversible pulpitisIrreversible pulpitis of second mandibular primary molar.PulpitisK04.0
IRCT20210419051016N1Esfahan University of Medical Sciences50
Not yet recruiting
Not Applicable
Comparison of Clinical and Radiographic Evaluation of the Effect of Decalcified Freeze Dried Bone Allograft(DFDBA) with Amniotic Membrane and Decalcified Freeze Dried Bone Allograft(DFDBA) with Platelet Rich Fibrin(PRF) Membrane in the Treatment of Intrabony Defects in Periodontitis PatientsHealth Condition 1: null- Chronic Periodontitis patients with interproximal bone defects of 5mm or more
CTRI/2018/04/012987Geetika Prabhakar
Not yet recruiting
Not Applicable
Comparison of Calcium Sulphate Hemihydrate And Calciun Sulphate Hemihydrate - PRF in Chronic Periodontitis Patients.
CTRI/2019/05/019260DrPayal Ramteke
Not yet recruiting
Phase 2
Comparison between efficiency of artificial bone particles with specialized human blood clot and artificial bone particles with liquified human blood clot in the treatment of bony defects in severe gum disease
CTRI/2022/09/046101Dr Sayali Gotpagar
Completed
Not Applicable
comparative evaluation of the effects of Bovine derived xenograft (osseograft TM) and combination of bovine derived xenograft and calcium sulphate hemihydrate (osseograftTM) , used for the treatment of bone defects due to diseases of gums, clinically and using radiograph
CTRI/2018/01/011245ikita Dilip Patil80